IMMUTEP LIMITED - AMER
2.0400
19-May-25 16:45:00
15 minutes delayed
Stocks
+0.0100
+0.49%
Today's range
2.0000 - 2.0800
ISIN
N/A
Source
NASDAQ
-
Immutep Quarterly Activities Report & Appendix 4C
28 Oct 2021 08:00:02 By Nasdaq GlobeNewswire
-
Immutep to Present Phase II TACTI-002 Data at SITC 2021
01 Oct 2021 08:00:02 By Nasdaq GlobeNewswire
-
Immutep Receives A$3.4 million R&D Tax Incentive from French Government
29 Sep 2021 08:00:00 By Nasdaq GlobeNewswire
-
Immutep to Present at Healthcare Investor Conferences
28 Sep 2021 08:00:01 By Nasdaq GlobeNewswire
-
21 Sep 2021 08:38:03 By Nasdaq GlobeNewswire
-
Immutep Completes Recruitment of 2nd line PD-1/PD-L1 refractory NSCLC Patients in TACTI-002
01 Sep 2021 08:00:00 By Nasdaq GlobeNewswire
-
Immutep’s Chinese Partner, Eoc Pharma, Expands Efti Trial Pipeline
31 Aug 2021 08:00:01 By Nasdaq GlobeNewswire
-
Immutep Announces Chinese Patent Grant for LAG-3 Antagonist Antibody LAG525
27 Aug 2021 08:00:00 By Nasdaq GlobeNewswire
-
05 Aug 2021 08:00:02 By Nasdaq GlobeNewswire
-
Immutep Quarterly Activities Report
13 Jul 2021 08:00:03 By Nasdaq GlobeNewswire